Publications by authors named "Dorcas Atibilla"
Article Synopsis
- - Malaria is a significant health issue for children in sub-Saharan Africa, and this study focused on understanding its prevalence in children aged 6 months to 10 years in Greater Accra, Ghana.
- - Researchers conducted a cross-sectional study involving over 16,000 children, finding that malaria prevalence was relatively low (3.3% in younger children and 4.9% in older children), with variations across districts.
- - Factors affecting malaria infection rates included older age and lack of window nets increasing risk, while living in urban areas decreased the likelihood of infection, suggesting targeted interventions are necessary in specific hotspots.
A vertically transmitted microsporidian, Microsporidia MB, with the ability to disrupt Plasmodium development was reported in Anopheles arabiensis from Kenya, East Africa. To demonstrate its range of incidence, archived DNA samples from 7575 Anopheles mosquitoes collected from Ghana were screened. MB prevalence was observed at 1.
View Article and Find Full Text PDFIntroduction: Ghana adopted the revised WHO recommendation on intermittent preventive treatment in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in 2012. This study has assessed the effectiveness and safety of this policy in Ghana.
Methods: A total of 1926 pregnant women enrolled at antenatal care (ANC) clinics were assessed for birth outcomes at delivery, and placental histology results for malaria infection were obtained from 1642 participants.
Anaemia in young sub-Saharan African children may be due to the double burden of malaria and iron deficiency. Primary analysis of a double-blind, cluster randomized trial of iron containing micronutrient powder supplementation in Ghanaian children aged 6 to 35 months found no difference in malaria risk between intervention and placebo groups. Here, we performed a secondary analysis of the trial data to assess the impact of long-term prophylactic iron fortificant on the risk of iron deficiency and anaemia in trial subjects.
View Article and Find Full Text PDFBackground: Malaria during pregnancy may result in unfavourable outcomes in both mothers and their foetuses. This study sought to document the current burden and factors associated with malaria and anaemia among pregnant women attending their first antenatal clinic visit in an area of Ghana with perennial malaria transmission.
Methods: A total of 1655 pregnant women aged 18 years and above with a gestational age of 13-22 weeks, who attended an antenatal care (ANC) clinic for the first time, were consented and enrolled into the study.
Article Synopsis
- This study aimed to estimate the prevalence of Plasmodium falciparum (PfPR) as part of a Phase III trial for a malaria vaccine, conducted across 8 sites in 6 African countries from 2011 to 2013.
- The research involved about 26,611 participants, focusing on various age groups, and utilized surveys during peak malaria transmission seasons to gather medical histories and blood samples for testing.
- Results indicated that PfPR varied significantly by region and age, showing lower prevalence in younger children in certain areas, while overall, higher prevalence was found in the 5-19 age group, with significant correlations identified between high parasitaemia and occurrences of fever and anemia.